Insulin Therapy in Type II Diabetics Increases Cancer Risk

First the researchers prove that insulin drugs used by type II diabetic patients increase the risk for cancer¹. Then the researchers try to explain why what they proved is no big deal – an apparent effort to escape the wrath of the insulin-prescribing medical profession.

This is not terribly difficult to figure out. Insulin is structured like growth hormone and neither is working well in a type II diabetic patient in the first place. Giving even more insulin not only forced sugar into cells causing toxic overload and potential mutation, but excess insulin readily induces growth hormone abnormalities (IGF-1 problems) leading to cancer risk. So why do doctors do it?

They do it because they are obsessed with changing numbers like fasting blood sugar or hemoglobin A1C. They think that if they change a number (called a biomarker) that they have improved health. There is no data to prove that changing numbers with drugs improves health. Sure you can lower blood sugar with insulin, however, where is the sugar going? Chances are it is causing serious health problems in its new location or the insulin itself in abnormal levels is directly causing health problems.

There is a lot of talk on Capital Hill that health care costs can be reduced by paying physicians to actually get people better. However, physicians don’t know how to get type II diabetics better. All physicians do is keep managing numbers, thinking they are doing a good job even if the person in front of them is gaining weight (as long as the numbers are reasonable). They are not blamed for the cancers they obviously cause as simply being overweight is itself a risk factor for excessive-insulin induced cancer.

The failure of doctors to heal difficult metabolic problems is a simple reflection of the woeful inadequacy of the Big-Pharma drug theory that is the essence of Western medicine.